6618.HK
Company Description
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 73.44B | 58.16B | 53.53B | 46.74B | 30.68B | 19.38B | 10.84B | 8.17B | 5.55B |
| Net Income | 5.38B | 4.16B | 2.14B | 380.11M | (1.07B) | (17.23B) | (971.80M) | 214.93M | 178.53M |
| EPS | 1.70 | 1.32 | 0.68 | 0.12 | -0.35 | -7.80 | -0.45 | 0.07 | 0.06 |
| Free Cash Flow | 0 | 4.29B | 4.54B | 5.86B | 2.93B | 3.68B | 404.28M | 184.81M | 27.49M |
| FCF / Share | N/A | 1.36 | 1.44 | 1.89 | 0.95 | 1.67 | 0.19 | 0.06 | 0.01 |
| Operating CF | 9.94B | 4.33B | 4.60B | 5.91B | 3.43B | 3.70B | 409.47M | 187.23M | 36.12M |
| Total Assets | 81.62B | 71.27B | 64.29B | 61.28B | 48.00B | 43.99B | 8.68B | 1.18B | 911.36M |
| Total Debt | 636.29M | 258.39M | 214.75M | 199.41M | 201.27M | 89.98M | 11.26M | 3.13M | 3.26M |
| Cash & Equiv | 31.81B | 22.63B | 15.04B | 18.72B | 17.25B | 32.27B | 4.97B | 16.21M | 7.40M |
| Book Value | 60.10B | 55.23B | 49.36B | 44.78B | 39.85B | 39.25B | (459.03M) | 749.22M | 662.62M |
| Return on Equity | 0.09 | 0.08 | 0.04 | 0.01 | -0.03 | -0.44 | N/A | 0.29 | 0.27 |
| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 | Q4 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 38.15B | 35.29B | 29.82B | 28.34B | 26.42B | 27.11B | 26.51B | 20.23B | 17.04B | 13.64B | 10.61B | 8.78B |
| Net Income | 2.78B | 2.60B | 2.12B | 2.04B | 580.48M | 1.56B | 156.55M | 223.55M | (618.36M) | (455.14M) | (11.88B) | (5.36B) |
| EPS | 0.86 | 0.82 | 0.67 | 0.65 | 0.19 | 0.49 | 0.05 | 0.07 | -0.20 | -0.15 | -5.24 | -2.49 |
| Free Cash Flow | 0 | 6.21B | 2.11B | 2.22B | 4.22B | 328.59M | 3.63B | 2.23B | 1.02B | 1.91B | 3.33B | 353.03M |
| FCF / Share | N/A | 1.94 | 0.67 | 0.71 | 1.35 | 0.10 | 1.16 | 0.71 | 0.33 | 0.63 | 1.47 | 0.16 |
| Operating CF | 4.06B | 6.24B | 2.10B | 2.23B | 4.24B | 368.08M | 3.65B | 2.26B | 1.50B | 1.93B | 3.34B | 359.67M |
| Total Assets | 81.62B | 78.46B | 71.27B | 67.22B | 64.29B | 61.35B | 61.28B | 52.85B | 48.00B | 46.50B | 43.99B | 11.39B |
| Total Debt | 636.29M | 429.69M | 258.39M | 217.71M | 214.75M | 216.74M | 199.41M | 194.30M | 201.27M | 115.48M | 89.98M | 53.57M |
| Cash & Equiv | 31.81B | 25.18B | 22.63B | 8.84B | 15.04B | 11.90B | 18.72B | 16.67B | 17.25B | 18.98B | 32.27B | 3.20B |
| Book Value | 60.10B | 57.97B | 55.23B | 52.13B | 49.36B | 48.68B | 44.78B | 42.35B | 39.85B | 39.55B | 39.25B | (5.83B) |
| Return on Equity | 0.05 | 0.04 | 0.04 | 0.04 | 0.01 | 0.03 | 0.00 | 0.01 | -0.02 | -0.01 | -0.30 | N/A |